CD8+ T cells
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
CD8+ T cells
Jul 14, 2024, 15:02 |
Insight
Bruno Giotti: Multiple gene programs and cellular subpopulations associated with patient prognosis in pleural mesothelioma
Bruno Giotti, Postdoctoral Researcher at Icahn School of Medicine at Mount Sinai, shared a post…
Jul 12, 2024, 11:40 |
Insight
Claire Lewis: Why do some cancer patients respond well to immunotherapy and others not?
Claire Lewis, Professor of Experimental Pathology at University of Sheffield, shared a post on LinkedIn about…
Jun 26, 2024, 04:38 |
Insight
Andy Minn: Summary of our paper on combining JAK inhibitors with anti-PD1 for lung cancer
Andy Minn, Professor at University of Pennsylvania School of Medicine, shared a post on X: "Summary…
May 12, 2024, 17:41 |
Insight
Marco Donia: Circadian rhythm, tumor infiltration of CD8+ T cells, and cancer immunotherapy
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared on LinkedIn: “Circadian…
Apr 26, 2024, 07:04 |
Blog
Rudi Schmidt: The PD1/PD-L1 checkpoint pathway is almost exclusively associated with cancer and immunotherapies
Rudi Schmidt, Chief Operating Officer at Institute for Healthier Living Abu Dhabi, shared on LinkedIn:…
All:
5
Posts:
1 - 100
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube